On February 14, the CLHIA responded to the Patented Medicines Review Board’s (PMPRB) consultation on draft guidelines to support implementation of the amendments to the Patented Medicines Regulations that come into effect July 1, 2020. Our submission was supportive of the proposed changes and we conclude that the proposed changes strike the right balance between reducing the high cost of prescription drugs in Canada, while continuing to ensure Canadians have access to affordable and necessary medications. The industry noted that we will continue to look for ways to support these efforts as the PMPRB moves towards implementation.